BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:INV-347 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of INV-347\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07153172-142@assetmemo.bio
DTSTAMP:20261121T005405Z
DTSTART;VALUE=DATE:20270915
DTEND;VALUE=DATE:20270916
SUMMARY:INV-347: Phase 1 readout est. (NCT07153172)
DESCRIPTION:INV-347\, phase 1\, Obesity.\nStudy: Safety Follow-up Study of 
 Participants Dosed With INV-347 in Study INV-CL-108\nEstimated primary com
 pletion: 15 September 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/inv-347#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07153172
URL:https://assetmemo.bio/drug/inv-347#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
